Last quarter (Q3 2024), Zevra Therapeutics's total revenue was $3.69M, a decrease of -56.38% from the same quarter last year. In Q3, Zevra Therapeutics's net income was $-33.23M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 14.46M	$ 27.46M	$ 10.46M	$ 28.65M	$ 13.29M	$ 12.84M
Cost of Revenue	$ 6.20M	$ 2.94M	$ 343.00K	$ 2.06M	$ -1.30M	$ 2.94M
Gross Profit	$ 8.27M	$ 24.52M	$ 10.12M	$ 26.59M	$ 11.98M	$ 9.89M
Operating Expense	$ 92.27M	$ 74.12M	$ 52.62M	$ 19.01M	$ 19.07M	$ 31.89M
Operating Income	$ -86.95M	$ -49.60M	$ -42.51M	$ 7.73M	$ -5.61M	$ -21.99M
Net Non Operating Interest Income Expense	$ -1.10M	$ -1.50M	$ -335.00K	$ -226.00K	$ -4.79M	$ -4.86M
Other Income Expense	$ -6.52M	$ -5.06M	$ -511.00K	$ 15.87M	$ 95.00K	$ -2.31M
Pretax Income	$ -83.64M	$ -46.05M	$ -42.33M	$ -8.52M	$ -12.79M	$ -24.54M
Tax Provision	$ 177.00K	$ ―	$ -786.00K	$ 34.00K	$ -34.00K	$ -22.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -84.72M	$ -46.05M	$ -41.54M	$ -62.90M	$ -12.76M	$ -24.52M
Basic EPS	$ -1.97	$ -1.30	$ -1.20	$ -2.11	$ -3.21	$ -0.83
Diluted EPS	$ -1.97	$ -1.30	$ -1.20	$ -2.11	$ -3.21	$ -0.83
Basic Average Shares	$ 166.21M	$ 35.45M	$ 34.49M	$ 29.77M	$ 3.98M	$ 29.65M
Diluted Average Shares	$ 166.21M	$ 35.45M	$ 34.49M	$ 29.77M	$ ―	$ 29.65M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 98.47M	$ 77.06M	$ 52.96M	$ 21.07M	$ 17.76M	$ 34.83M
Net Income From Continuing And Discontinued Operation	$ -83.82M	$ -46.05M	$ -41.54M	$ -8.55M	$ -12.76M	$ -24.52M
Normalized Income	$ -63.76M	$ ―	$ -43.12M	$ -4.67M	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -82.54M	$ -44.55M	$ -41.99M	$ -8.14M	$ -5.70M	$ -25.05M
EBITDA	$ -77.74M	$ -43.54M	$ -41.05M	$ -7.89M	$ -5.43M	$ -23.09M

Currency in USD

Zevra Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing